This is a routine tax-withholding sale by a director with no discretionary signal. Monitor for any larger discretionary insider sales in the coming weeks, but this filing alone does not warrant a trading response.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 13 $125.29entry
- T+1 · 3mo ago −5.36%α −5.17% · $118.57
- T+5 · 3mo ago +8.73%α +10.70% · $136.23
- T+20 · 2mo ago +1.54%α +3.29% · $127.22
- T+60 · 11d ago −3.59%α +1.88% · $120.79
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Katryn Blake filed a Form 144 to sell 2,240 shares of Twist Bioscience common stock, valued at approximately $275,250. The sale is a tax-withholding transaction tied to the settlement of a vested equity award, not a discretionary portfolio liquidation. Given the small proportional size relative to the company's $8.2B market cap and the tax-motivated nature, this filing carries minimal standalone signal for the stock.
Key Facts
- Director Katryn Blake filed Form 144 to sell 2,240 shares of Twist Bioscience common stock.
- The proposed sale value is approximately $275,250.
- The shares were acquired on 08/05/2026 via Restricted Stock Vesting from the issuer.
- The filing states the sale is to cover a tax obligation from the settlement of a vested equity award distribution.
- The sale is to be executed through Fidelity Brokerage Services LLC.
Financial Impact
Proposed sale of 2,240 shares valued at ~$275,250, representing a negligible fraction of the company's $8.2B market cap.
Risk Factors
- Insider selling could increase if other directors or officers file additional Form 144s.
- The stock's elevated valuation (94% analyst bullish consensus) introduces downside risk if fundamentals disappoint.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-005946 |
| Document: 0001959173-26-005946-index.html | 0001959173-26-005946 |
| Document: 0001959173-26-005946.txt | 0001959173-26-005946 |
Track record
47 reports on TWST
8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $111.60 +6.26% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $111.60 +6.12% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $111.60 +6.31% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $111.60 +5.67% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $111.60 +7.28% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $111.60 −15.54% settles Dec 9
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $111.60 −7.61% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $111.60 −7.47% settles Dec 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers